Abstract
The sensitivity of 7 human non-small cell lung cancer cell lines to each of 7 cytotoxic drugs was determined. None of the cell lines used in these experiments had been previously exposed to cytotoxic drugs in vitro. A pattern of cross-resistance (P less than 0.05) between the drugs adriamycin (ADR), vincristine (VC) and etoposide (VP16) was noted similar to that seen in other models. The calcium antagonist verapamil (6.6 microM) was shown to increase sensitivity (up to 29-fold) to ADR, VC or VP16 in 5 cell lines. For 2 of the cell lines (A549 and WIL) 2.2 microM verapamil increased VP16 cytotoxicity (up to 4-fold). Drug accumulation studies in 2 cell lines (A549 and SK-MES-1) showed that 6.6 microM verapamil increased intracellular levels of VC up to 4-fold with the greatest increase seen in the cell line (SK-MES-1) for which verapamil produced the greatest increase in cytotoxicity (10-fold). For ADR and VP16 increases in drug accumulation were smaller (up to 1.6-fold). Our data support a potential clinical role for verapamil in overcoming cytotoxic drug resistance in human lung cancer.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Merry, S., Courtney, E., Fetherston, C. et al. Circumvention of drug resistance in human non-small cell lung cancer in vitro by verapamil. Br J Cancer 56, 401–405 (1987). https://doi.org/10.1038/bjc.1987.214
Issue Date:
DOI: https://doi.org/10.1038/bjc.1987.214
This article is cited by
-
Drug repositioning in non-small cell lung cancer (NSCLC) using gene co-expression and drug–gene interaction networks analysis
Scientific Reports (2022)
-
Expression of verapamil hypersensitivity in multidrug-resistant cells grown as multicellular spheroids
Cancer Chemotherapy and Pharmacology (1990)
-
Identification of anthracyclines and related agents that retain preferential activity over Adriamycin in multidrug-resistant cell lines, and further resistance modification by verapamil and cyclosporin A
Cancer Chemotherapy and Pharmacology (1989)
-
Effect of finoptin on doxorubicin accumulation in leukemia P388 cells with induced antibiotic resistance
Bulletin of Experimental Biology and Medicine (1989)